Pricing Log in Create free account

NanoViricides, Inc. (NNVC) vs Veru Inc. (VERU)

NanoViricides, Inc. and Veru Inc. are both Biotechnology companies. NanoViricides, Inc. and Veru Inc. are of similar size ($35.1M and $32.9M). Across the 10 metrics below, Veru Inc. leads on 7 and NanoViricides, Inc. on 3.

Valuation

Metric NNVC VERU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.65 9.40
P/B 3.09 1.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.44 9.02
Earnings yield (30.08%) (27.13%) (32.88%)
Free cash flow yield (28.98%) (52.80%) (23.13%)

Profitability

Metric NNVC VERU Biotechnology median
Gross margin 0.00% 43.39% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.46%) (62.25%) (51.96%)
Return on assets (87.91%) (42.29%) (46.06%)
Return on invested capital (88.16%) (464.03%) 0.00%

Growth

Metric NNVC VERU Biotechnology median
Revenue growth (TTM) — 14.18% 6.76%
EPS growth (last fiscal year) 34.92% 44.64% 29.88%
Revenue growth, 5-year CAGR — (11.89%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NNVC VERU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.66 4.42 4.97
Net debt to EBITDA 0.36 0.74 1.01

Dividend

Metric NNVC VERU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NNVC VERU Biotechnology median
Market cap 32.92m 35.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack